Literature DB >> 16103632

Increased seroprevalence of human herpesvirus 8 in patients with hematological disorders.

Wen-Hui Tsai1, Yuan-Ming Lee, Benjamin Ing-Tiau Kuo, Chi Kuan Ho, Pen-Tung Liao, Ming-Der Liu, Yu Ru Kou, Hui-Chi Hsu.   

Abstract

Human herpesvirus 8 (HHV8) has been consistently linked to Kaposi's sarcoma and many hematological diseases such as pleural effusion lymphoma, multicentric Castleman's disease, some lymphoproliferative diseases and posttransplantation bone marrow failure. However, whether patients with hematological disorders are at a higher risk of HHV8 infection has not been determined. In this study, indirect immunofluorescence was used to detect antibodies against lytic antigens of HHV8 in 265 patients with hematological disorders. Our data showed that 24.5% of patients (65/265) were seropositive for HHV8 IgG antibody, which was significantly higher than in our general population (p < 0.001). A significantly higher seropositive rate can be found in patients with lymphoma, leukemia, autoimmune cytopenias and myeloproliferative disorders, but not in patients with myeloma or aplastic anemia. No difference in the seropositive rate is associated with gender or age. We conclude that some patients with hematological disorders are at a higher risk of HHV8 infection. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16103632     DOI: 10.1159/000086582

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  3 in total

1.  Bone Marrow Involvement in Multicentric Castleman Disease in a HIV Negative Patient.

Authors:  Pallavi Agrawal; Shano Naseem; Neelam Varma; Prashant Sharma; Pankaj Malhotra; Subhash Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2013-03-13       Impact factor: 0.900

2.  Immunohistochemical study association between human herpesvirus 8 and multiple myeloma.

Authors:  Mohammad Hadi Sadeghian; Mehrdad Katebi; Hossein Ayatollahi; Mohammad Reza Keramati
Journal:  Int J Hematol       Date:  2008-07-16       Impact factor: 2.490

3.  Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.

Authors:  Fahad Mukhtar; Mmadili Ilozumba; Ovie Utuama; Oguz Cimenler
Journal:  JAMA Oncol       Date:  2018-01-01       Impact factor: 31.777

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.